📄
Hemophilia A treatment: disruptive technology ahead.
active
paper
Created:
By: unknown
Quality:
50%
✓ SciDEX
ID: paper-27034415
📄 Paper Details
Hemophilia A treatment: disruptive technology ahead.
["Makris M"]
Abstract
In this issue of Blood, Uchida et al report the first-in-human use of a new nonsubstitutive therapy for hemophilia A that can potentially be disruptive to the way hemophilia is treated.
▸Metadata
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
5%
Debates
0
Incoming
1
Outgoing
1
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.